1093 — CSPC Pharmaceutical Share Price
0.000.00%
Last trade - 00:00- HK$69.72bn
- HK$63.19bn
- CNY29.01bn
- 90
- 56
- 48
- 74
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 13.03 | ||
| PEG Ratio (f) | 1.22 | ||
| EPS Growth (f) | 11.98% | ||
| Dividend Yield (f) | 4.56% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.05 | ||
| Price to Tang. Book | 2.25 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.28 | ||
| EV to EBITDA | 8.35 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.43% | ||
| Return on Equity | 13.22% | ||
| Operating Margin | 19.69% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 24,942.2 | 27,866.87 | 30,936.9 | 31,450.11 | 29,009.25 | 30,687.83 | 31,129.85 | 5.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +28.19 | +14.87 | +9.08 | -3.19 | -25.48 | +19.62 | -1.35 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CSPC Pharmaceutical Group Ltd is an investment holding company primarily engaged in the manufacture and sale of pharmaceutical products. The Company operates its business through three segments. The Finished Drugs segment in engaged in the research and development, manufacture and sale of pharmaceutical products and licensing business. The Bulk Products segment is engaged in the manufacture and sale of vitamin C, and antibiotic products in bulk powder form. The Functional Food and Others segment is engaged in the manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. The Company’s product therapeutic areas include nervous system, oncology, anti-infectives, cardiovascular, respiratory system, digestion and metabolism and others. The Company conducts its business in the domestic and overseas markets.
Directors
- Dongchen Cai CHM (67)
- Cuilong Zhang VCH (52)
- Kin Man Chak EDR (55)
- Hao Jiang EDR (37)
- Chunlei Li EDR (44)
- Weidong Pan EDR (51)
- Huaiyu Wang EDR (58)
- Qingxi Wang EDR (55)
- Zhenguo Wang EDR (51)
- Tai Lo SEC (66)
- Chun Kwok Au NID (48)
- Chuan Chen NID (57)
- Cheuk Kin Law NID (58)
- Bo Wang NID (60)
- Hongguang Wang NID (58)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 16th, 1992
- Public Since
- June 21st, 1994
- No. of Employees
- 21,400
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 11,543,701,732
- Address
- No.896 Zhongshandong Street, SHIJIAZHUANG, 050035
- Web
- https://www.cspc.com.hk/
- Phone
- +86 31187037015
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for 1093
CSPC Pharmaceutical Group Ltd Annual Shareholders Meeting
Dividend For 1093.HK - 0.1000 HKD
Dividend For CSPCY.PK - 0.0514 USD
Half Year 2025 CSPC Pharmaceutical Group Ltd Earnings Release
Similar to 1093
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
What is the CSPC Pharmaceutical share price?
As of Today at 20:08 UTC, shares in CSPC Pharmaceutical are trading at HK$6.11. This share price information is delayed by 15 minutes.
How has the CSPC Pharmaceutical share price performed this year?
Shares in CSPC Pharmaceutical last closed at HK$6.11 and the price had moved by -6.29% over the past 365 days. In terms of relative price strength the CSPC Pharmaceutical share price has underperformed the FTSE Developed Asia Pacific Index by -5.22% over the past year.
What are the analyst and broker recommendations for CSPC Pharmaceutical?
The overall consensus recommendation for CSPC Pharmaceutical is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the CSPC Pharmaceutical dividend yield?
The CSPC Pharmaceutical dividend yield is 4.26% based on the trailing twelve month period.
Does CSPC Pharmaceutical pay a dividend?
Last year, CSPC Pharmaceutical paid a total dividend of CNY0.24, and it currently has a trailing dividend yield of 4.26%.Looking ahead, shares in CSPC Pharmaceutical are due to go ex-dividend on 2025-06-04 and the next dividend pay date is 2025-07-18.
When does CSPC Pharmaceutical next pay dividends?
CSPC Pharmaceutical are due to go ex-dividend on 2025-06-04 and the next dividend pay date is 2025-07-18. The historic dividend yield on CSPC Pharmaceutical shares is currently 4.26%.
How do I buy CSPC Pharmaceutical shares?
To buy shares in CSPC Pharmaceutical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CSPC Pharmaceutical?
As of the previous close price of HK$6.11, shares in CSPC Pharmaceutical had a market capitalisation of HK$69.72bn.
Where are CSPC Pharmaceutical shares listed?
Here are the trading details for CSPC Pharmaceutical:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1093
What kind of share is CSPC Pharmaceutical?
Based on an overall assessment of its quality, value and momentum CSPC Pharmaceutical is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CSPC Pharmaceutical share price forecast for 2025?
The analyst consensus target price for shares in CSPC Pharmaceutical is HK$6.70. That is 9.61% above the last closing price of HK$6.11.
Analysts covering CSPC Pharmaceutical currently have a consensus Earnings Per Share (EPS) forecast of CNY0.44 for the next financial year.
Find out moreWhat is the trend in the CSPC Pharmaceutical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CSPC Pharmaceutical. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +3.92%.
As of the last closing price of HK$6.11, shares in CSPC Pharmaceutical were trading +16.07% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CSPC Pharmaceutical PE Ratio?
The CSPC Pharmaceutical PE ratio based on its reported earnings over the past 12 months is 13.03. The shares last closed at HK$6.11.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CSPC Pharmaceutical?
CSPC Pharmaceutical's management team is headed by:
- Dongchen Cai - CHM
- Cuilong Zhang - VCH
- Kin Man Chak - EDR
- Hao Jiang - EDR
- Chunlei Li - EDR
- Weidong Pan - EDR
- Huaiyu Wang - EDR
- Qingxi Wang - EDR
- Zhenguo Wang - EDR
- Tai Lo - SEC
- Chun Kwok Au - NID
- Chuan Chen - NID
- Cheuk Kin Law - NID
- Bo Wang - NID
- Hongguang Wang - NID